Detalhe da pesquisa
1.
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
Cell
; 163(4): 988-98, 2015 Nov 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26544943
2.
Gene signature discovery and systematic validation across diverse clinical cohorts for TB prognosis and response to treatment.
PLoS Comput Biol
; 19(7): e1010770, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37471455
3.
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
Clin Microbiol Rev
; 35(3): e0022721, 2022 09 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35311552
4.
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
PLoS Pathog
; 17(11): e1010016, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34843602
5.
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
PLoS Med
; 17(5): e1003117, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32442195
6.
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
PLoS Med
; 17(2): e1003038, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32092060
7.
Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
PLoS Pathog
; 14(2): e1006888, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29474461
8.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Lancet
; 392(10143): 232-243, 2018 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30047376
9.
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
J Infect Dis
; 217(8): 1280-1288, 2018 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-29325070
10.
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial.
J Infect Dis
; 215(9): 1376-1385, 2017 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28199679
11.
Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.
PLoS Pathog
; 11(2): e1004658, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25723536
12.
T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents.
J Immunol
; 195(10): 4595-603, 2015 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26466957
13.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26833336
14.
Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
J Infect Dis
; 214(3): 379-89, 2016 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26951820
15.
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
J Infect Dis
; 213(4): 541-50, 2016 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26475930
16.
Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
N Engl J Med
; 369(22): 2083-92, 2013 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-24099601
17.
Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
J Virol
; 89(20): 10303-18, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26223634
18.
Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
JAMA
; 315(15): 1610-23, 2016 Apr 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27092831
19.
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
N Engl J Med
; 366(14): 1275-86, 2012 Apr 05.
Artigo
Inglês
| MEDLINE | ID: mdl-22475592
20.
Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication.
J Virol
; 88(2): 1354-65, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24227851